Eledon Pharmaceuticals, Inc. (ELDN) Financial Statements (2024 and earlier)

Company Profile

Business Address 19900 MACARTHUR BLVD.
IRVINE, CA 92612
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:71,400,00046,485,00056,409,00065,889,00070,460,00076,677,000
Cash and cash equivalents40,947,00046,485,00056,409,00065,889,00070,460,00076,677,000
Short-term investments30,431,000     
Other undisclosed cash, cash equivalents, and short-term investments22,000     
Prepaid expense561,000792,000966,000478,000923,0001,233,000
Other current assets238,00047,00028,00057,00032,00017,000
Other undisclosed current assets1,423,0001,580,0002,115,0001,141,0001,373,0001,398,000
Total current assets:73,622,00048,904,00059,518,00067,565,00072,788,00079,325,000
Noncurrent Assets
Operating lease, right-of-use asset553,000647,000739,000832,000581,000675,000
Intangible assets, net (including goodwill)    48,648,00048,648,00048,648,000
Goodwill    48,648,00048,648,00048,648,000
Other noncurrent assets224,000369,000150,000155,000303,000344,000
Other undisclosed noncurrent assets32,386,00032,386,00032,386,00032,386,00032,386,00032,386,000
Total noncurrent assets:33,163,00033,402,00033,275,00082,021,00081,918,00082,053,000
TOTAL ASSETS:106,785,00082,306,00092,793,000149,586,000154,706,000161,378,000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3,684,0003,953,0004,286,0006,572,0003,578,0002,000,000
Employee-related liabilities1,281,0001,061,000814,000
Accounts payable2,197,0002,852,0002,200,0003,859,0001,318,0001,026,000
Accrued liabilities1,487,0001,101,0002,086,0001,432,0001,199,000160,000
Other undisclosed current liabilities1,216,0001,525,0002,189,000(292,000)(302,000)958,000
Total current liabilities:4,900,0005,478,0006,475,0006,280,0003,276,0002,958,000
Noncurrent Liabilities
Long-term debt and lease obligation:    461,000299,000350,000
Liabilities, other than long-term debt1,936,0002,036,0002,135,0001,752,0001,752,0001,752,000
Deferred income tax liabilities1,752,0001,752,0001,752,0001,752,0001,752,0001,752,000
Operating lease, liability184,000284,000383,000461,000299,000350,000
Total noncurrent liabilities:1,936,0002,036,0002,135,0002,213,0002,051,0002,102,000
Total liabilities:6,836,0007,514,0008,610,0008,493,0005,327,0005,060,000
Equity
Equity, attributable to parent99,949,00074,792,00084,183,000141,093,000149,379,000156,318,000
Common stock23,00014,00014,00014,00014,00014,000
Additional paid in capital323,142,000288,415,000287,034,000285,560,000283,375,000281,067,000
Accumulated deficit(223,216,000)(213,637,000)(202,865,000)(144,481,000)(134,010,000)(124,763,000)
Total equity:99,949,00074,792,00084,183,000141,093,000149,379,000156,318,000
TOTAL LIABILITIES AND EQUITY:106,785,00082,306,00092,793,000149,586,000154,706,000161,378,000

Income Statement (P&L) (USD)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Operating expenses(10,354,000)(11,110,000)(58,688,000)(10,598,000)(9,283,000)(9,859,000)
Operating loss:(10,354,000)(11,110,000)(58,688,000)(10,598,000)(9,283,000)(9,859,000)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
775,000338,000304,000127,00036,000(5,000)
Loss from continuing operations:(9,579,000)(10,772,000)(58,384,000)(10,471,000)(9,247,000)(9,864,000)
Loss before gain (loss) on sale of properties:(10,471,000)(9,247,000)(9,864,000)
Net loss available to common stockholders, diluted:(9,579,000)(10,772,000)(58,384,000)(10,471,000)(9,247,000)(9,864,000)

Comprehensive Income (USD)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Net loss:(9,579,000)(10,772,000)(58,384,000)(10,471,000)(9,247,000)(9,864,000)
Comprehensive loss, net of tax, attributable to parent:(9,579,000)(10,772,000)(58,384,000)(10,471,000)(9,247,000)(9,864,000)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: